Murphy et al1 state that patients with autosomal dominant polycystic kidney disease (ADPKD) of childbearing potential could benefit from preimplantation genetic diagnosis (PGD) counseling. This benefit may extend to patients with ADPKD outside North America; however, current circumstances in other countries such as China make it challenging or impossible to obtain. Although ADPKD affects about 1.5 million people in China,2 financial barriers prohibit access to PGD and counseling despite patients’ desire for it.